Cite
MLA Citation
N. Ruperto et al.. “AB1182 Efficacy and safety of canakinumab, fully human anti-interleukin-1beta antibody, in systemic juvenile idiopathic arthritis.” Annals of the rheumatic diseases, vol. 71, n.d., p. 705. http://access.bl.uk/ark:/81055/vdc_100135556407.0x00005d